yes, but randomization does not guarantee equivalency of all variables at baseline. its not uncommon for a few baseline parameters to still be skewed despite others being evenly split. the baseline is just such an easy thing to show in the graph that i found it surprising they didnt include it since it would clearly drive home the point of efti's MOA being clinically confirmed.
anyway, i messaged marc and hope he is able to confirm the baseline cd8 was the same for both groups - any pharma partner/acquirer would require this information
otherwise, presentation looks great!
Ann: Immutep Corporate Presentation, page-15
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.015(3.26%) |
Mkt cap ! $529.0M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.5¢ | 44.0¢ | $384.7K | 859.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 540198 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 115504 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
44.5¢ |
Change
-0.015 ( 2.20 %) |
||||
| Open | High | Low | Volume | ||
| 45.0¢ | 45.3¢ | 44.0¢ | 239211 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| IMM (ASX) Chart |